HK1130175A1 - Tansdermally absorbable preparation comprising anti-dementia agent - Google Patents

Tansdermally absorbable preparation comprising anti-dementia agent

Info

Publication number
HK1130175A1
HK1130175A1 HK09108096.7A HK09108096A HK1130175A1 HK 1130175 A1 HK1130175 A1 HK 1130175A1 HK 09108096 A HK09108096 A HK 09108096A HK 1130175 A1 HK1130175 A1 HK 1130175A1
Authority
HK
Hong Kong
Prior art keywords
tansdermally
absorbable preparation
dementia agent
dementia
agent
Prior art date
Application number
HK09108096.7A
Other languages
English (en)
Inventor
Takeshi Ito
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of HK1130175A1 publication Critical patent/HK1130175A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK09108096.7A 2006-05-08 2009-09-04 Tansdermally absorbable preparation comprising anti-dementia agent HK1130175A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79829606P 2006-05-08 2006-05-08
PCT/JP2006/325813 WO2007129427A1 (ja) 2006-05-08 2006-12-25 抗認知症薬物の経皮吸収製剤

Publications (1)

Publication Number Publication Date
HK1130175A1 true HK1130175A1 (en) 2009-12-24

Family

ID=38667540

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108096.7A HK1130175A1 (en) 2006-05-08 2009-09-04 Tansdermally absorbable preparation comprising anti-dementia agent

Country Status (17)

Country Link
US (2) US7858114B2 (xx)
EP (1) EP2016939B1 (xx)
JP (1) JP5122445B2 (xx)
KR (1) KR20090009951A (xx)
CN (1) CN101460156B (xx)
AU (1) AU2006343077B2 (xx)
BR (1) BRPI0621655A2 (xx)
CA (1) CA2651596C (xx)
ES (1) ES2466647T3 (xx)
HK (1) HK1130175A1 (xx)
IL (1) IL195174A0 (xx)
IN (1) IN266817B (xx)
MY (1) MY149152A (xx)
NO (1) NO20084614L (xx)
NZ (1) NZ572809A (xx)
RU (1) RU2428179C2 (xx)
WO (1) WO2007129427A1 (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100048628A1 (en) * 2006-12-01 2010-02-25 Sumiyo Nishi Method for suppressing discoloration over time of adhesive preparation containing donepezil
RU2452474C2 (ru) * 2006-12-01 2012-06-10 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
US20110104247A1 (en) * 2008-03-25 2011-05-05 Takeshi Ito Composition for stabilizing beta-blocker and transdermally absorbable preparation comprising the same
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
EP2279739B2 (en) * 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezil-containing patch preparation and packaging thereof
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
BRPI0917862A2 (pt) * 2008-09-30 2015-11-24 Teikoku Pharma Usa Inc composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
US20100278895A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
KR101325104B1 (ko) * 2009-09-16 2013-11-07 주식회사 삼양바이오팜 경피 투여 제형 및 그 제조 방법
US20120282303A1 (en) * 2009-12-16 2012-11-08 Takeshi Ito Percutaneous absorption preparation comprising anti-dementia drug
JP2012236773A (ja) 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
US20120283670A1 (en) * 2009-12-16 2012-11-08 Takeshi Ito Percutaneous absorption preparation comprising anti-dementia drug
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
WO2011076621A2 (de) * 2009-12-22 2011-06-30 Acino Ag Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
NZ605352A (en) * 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
RS54173B1 (en) * 2010-12-14 2015-12-31 Acino Ag TRANSDERMAL THERAPY SYSTEM FOR ACTIVE SUBSTANCE
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
KR101054317B1 (ko) 2011-01-28 2011-08-08 신신제약 주식회사 리바스티그민을 함유하는 경피흡수제제
KR101317158B1 (ko) * 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
EP2711002A4 (en) 2011-05-20 2014-10-29 Sk Chemicals Co Ltd PLASTER WITH RIVASTIGMIN
KR101395557B1 (ko) * 2011-08-25 2014-05-16 아이큐어 주식회사 경피 흡수 제제 및 그 제조방법
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
KR101964295B1 (ko) * 2012-09-05 2019-04-01 주식회사 한독 피부 자극이 감소된 메만틴 경피전달 시스템
BR112015013675B1 (pt) * 2012-12-13 2022-04-26 H. Lundbeck A/S Composição compreendendo vortioxetina e donepezil e usos dos mesmos
JP6151935B2 (ja) * 2013-03-11 2017-06-21 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
EP3107532B1 (en) 2014-02-20 2020-09-23 Nal Pharmaceutical Group Limited Transdermal drug delivery system containing donepezil
JP2018518502A (ja) 2015-06-22 2018-07-12 コリウム インターナショナル， インコーポレイテッド 難溶性治療剤を含む経皮接着性組成物
CN107530278A (zh) 2015-06-29 2018-01-02 积水化学工业株式会社 芯壳结构体及外用剂
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
JP7251033B2 (ja) * 2016-07-27 2023-04-04 コリウム， エルエルシー ドネペジル経皮送達システム
EP3490559A1 (en) * 2016-07-27 2019-06-05 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
CN109789113A (zh) * 2016-07-27 2019-05-21 考里安国际公司 美金刚透皮递送系统
US20200009174A1 (en) * 2017-02-28 2020-01-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN108096690B (zh) * 2017-04-07 2019-08-20 杭州多泰科技有限公司 一种诱导循环肿瘤细胞转移的可移植支架的制备方法
KR102033686B1 (ko) 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
CN111132669A (zh) * 2017-07-26 2020-05-08 考里安公司 具有带溶剂填充孔的微孔膜的透皮递送系统
CN111818914A (zh) 2017-12-13 2020-10-23 考里安公司 透皮药物递送期间创建储库的方法
AU2018392686A1 (en) 2017-12-20 2020-07-09 Corium Pharma Solutions, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
CN108926549A (zh) * 2018-09-27 2018-12-04 安徽安科余良卿药业有限公司 卡巴拉汀凝胶贴膏及其制备方法
KR102489860B1 (ko) * 2021-09-02 2023-01-19 동아에스티 주식회사 메만틴 에난트산염을 포함하는 치매 치료용 경피흡수 제제
CN115957200A (zh) * 2023-02-23 2023-04-14 广州新济药业科技有限公司 一种美金刚透皮贴剂及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003998A1 (en) 1989-09-14 1991-04-04 Cygnus Research Corporation Transdermal delivery device having delayed onset
JP2977254B2 (ja) 1990-09-04 1999-11-15 積水化学工業株式会社 経皮吸収貼付剤
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
JPH06199659A (ja) * 1992-10-28 1994-07-19 Hisamitsu Pharmaceut Co Inc 経皮治療用装置
DE69401945T3 (de) * 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
DE19653605C2 (de) 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
JPH10315016A (ja) 1997-05-15 1998-12-02 Nissan Diesel Motor Co Ltd チャック装置
JP3987655B2 (ja) 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
GB9917290D0 (en) 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
EP1340496A4 (en) * 2000-11-07 2004-04-14 Hisamitsu Pharmaceutical Co PHARMACEUTICAL PREPARATION OF THE PERCUTANEOUS ABSORPTION TYPE
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
JP4394443B2 (ja) * 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
JP4274951B2 (ja) * 2004-01-07 2009-06-10 久光製薬株式会社 異型断面繊維を使用した支持体を有するテーピング型貼付剤
US20080038328A1 (en) * 2004-05-28 2008-02-14 Naruhito Higo Pasting Preparation

Also Published As

Publication number Publication date
AU2006343077A1 (en) 2007-11-15
US20110059141A1 (en) 2011-03-10
CN101460156A (zh) 2009-06-17
CA2651596A1 (en) 2007-11-15
AU2006343077B2 (en) 2012-11-08
IN266817B (xx) 2015-06-03
JPWO2007129427A1 (ja) 2009-09-17
MY149152A (en) 2013-07-15
IL195174A0 (en) 2009-08-03
ES2466647T3 (es) 2014-06-10
US20070259028A1 (en) 2007-11-08
EP2016939B1 (en) 2014-03-19
NZ572809A (en) 2011-02-25
KR20090009951A (ko) 2009-01-23
JP5122445B2 (ja) 2013-01-16
RU2008148131A (ru) 2010-06-20
EP2016939A4 (en) 2013-01-09
NO20084614L (no) 2009-02-06
US7858114B2 (en) 2010-12-28
RU2428179C2 (ru) 2011-09-10
EP2016939A1 (en) 2009-01-21
CN101460156B (zh) 2011-06-08
CA2651596C (en) 2014-03-25
BRPI0621655A2 (pt) 2011-12-20
WO2007129427A1 (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
HK1130175A1 (en) Tansdermally absorbable preparation comprising anti-dementia agent
IL245513A0 (en) Medical preparations containing ingenol-3-angelate
HK1207009A1 (en) Absorbable hemostat
EP2016941A4 (en) PREPARATION OF TRANSDERMALLY RESORBABLE DONEPZIL
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
EP2049713A4 (en) TISSUE REJECTION
HK1146704A1 (en) Transdermally absorbable preparation
EP1857103A4 (en) TRANSDERMALLY ABSORBABLE PREPARATION
EP2027849A4 (en) TOPICAL SKIN PREPARATION
GB2458228B (en) External preparation for skin
IL198651A0 (en) COMPOSITION COMPRISING (-)-Ôêå9-TRANS-TETRAHYDROCANNABIONOL
IL197235A0 (en) Therapeutic compositions
EP1994933A4 (en) AQUEOUS COMPOSITION
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
EP2062892A4 (en) AGENT ENHANCING HYPERTENSION
GB0625783D0 (en) Medicament
EP2030629A4 (en) AGENT FOR IMPROVING LIPID METABOLISM
EP2124959A4 (en) PHARMACEUTICAL COMPOSITION
GB0619375D0 (en) Wound healing compositions
EP2060263A4 (en) AGENT FOR IMPROVING LIPID METABOLISM
GB0705395D0 (en) Breath deodoriser
GB0615064D0 (en) Medicament
ZA200904476B (en) Wound bed preparation
IL208396A0 (en) Guided surgery
GB2442539B (en) Cutlery forceps

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141225